Demos, a medical doctor who was the Vice President of Drug Safety and Pharmacovigilance and member of the drug label team at ...
George Demos admitted selling more than 60,000 company shares just before news broke regarding an issue with one of the ...
George Demos, 64, formerly of Acadia Pharmaceuticals Inc., admitted selling more than 60,000 company shares just before news broke regarding an issue with one of the company's products ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback